Literature DB >> 17705137

Bim regulates BCR-induced entry of B cells into the cell cycle.

Andrew Craxton1, Kevin E Draves, Edward A Clark.   

Abstract

BH3-only Bcl-2 homologs are key regulators of the intrinsic apoptotic pathway. In particular, Bim, is critical for mediating apoptosis of hematopoietic cells including B cells. While studies using Bcl-2 Tg mice have defined an important role for Bcl-2 in cell cycle control, the role of BH3-only proteins is less clear. Using Bim KO mice, we show that Bim is required for B cells to enter the cell cycle normally. Bim KO B cells had reduced cell division compared to WT B cells in response to BCR, TLR3 or TLR4 signaling, whereas Bim deficiency did not affect TLR9-induced B cell division. Cell cycle progression in BCR- and LPS-stimulated Bim KO B cells was blocked at the G0-G1 stage. BCR-induced p130 degradation and pRb hyperphosphorylation on Ser807/811, which are critical for G1 entry, were reduced in Bim KO compared to WT B cells. Likewise, BCR-induced p27(Kip1) degradation was decreased in Bim KO compared to WT B cells. These defects in BCR-induced cell cycle entry correlated with a proximal defect in BCR-mediated intracellular calcium release in Bim KO B cells. Our results suggest that the balance of pro- and anti-apoptotic Bcl-2 family proteins is critical for controlling both cell cycle progression and apoptosis in B cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705137     DOI: 10.1002/eji.200737327

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  BCR-induced superoxide negatively regulates B-cell proliferation and T-cell-independent type 2 Ab responses.

Authors:  Sabrina M Richards; Edward A Clark
Journal:  Eur J Immunol       Date:  2009-12       Impact factor: 5.532

2.  Bim is required for T-cell allogeneic responses and graft-versus-host disease in vivo.

Authors:  Yu Yu; Jing Yu; Cristina Iclozan; Kane Kaosaard; Claudio Anasetti; Xue-Zhong Yu
Journal:  Am J Blood Res       Date:  2012-01-01

Review 3.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15

Review 4.  Regulation of B-cell entry into the cell cycle.

Authors:  Sabrina Richards; Chie Watanabe; Lorna Santos; Andrew Craxton; Edward A Clark
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

5.  Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.

Authors:  Lindsay M Morton; Mark P Purdue; Tongzhang Zheng; Sophia S Wang; Bruce Armstrong; Yawei Zhang; Idan Menashe; Nilanjan Chatterjee; Scott Davis; Qing Lan; Claire M Vajdic; Richard K Severson; Theodore R Holford; Anne Kricker; James R Cerhan; Brian Leaderer; Andrew Grulich; Meredith Yeager; Wendy Cozen; Shelia Hoar Zahm; Stephen J Chanock; Nathaniel Rothman; Patricia Hartge
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

6.  BH3-only molecule Bim mediates β-cell death in IRS2 deficiency.

Authors:  Decheng Ren; Juan Sun; Liqun Mao; Honggang Ye; Kenneth S Polonsky
Journal:  Diabetes       Date:  2014-04-23       Impact factor: 9.461

7.  IER3IP1 deficiency leads to increased β-cell death and decreased β-cell proliferation.

Authors:  Juan Sun; Decheng Ren
Journal:  Oncotarget       Date:  2017-05-25

8.  Dependence of p53-deficient cells on the DHX9 DExH-box helicase.

Authors:  Teresa Lee; Jerry Pelletier
Journal:  Oncotarget       Date:  2017-05-09

9.  A pathway switch directs BAFF signaling to distinct NFκB transcription factors in maturing and proliferating B cells.

Authors:  Jonathan V Almaden; Rachel Tsui; Yi C Liu; Harry Birnbaum; Maxim N Shokhirev; Kim A Ngo; Jeremy C Davis-Turak; Dennis Otero; Soumen Basak; Robert C Rickert; Alexander Hoffmann
Journal:  Cell Rep       Date:  2014-12-11       Impact factor: 9.423

Review 10.  Perturbing mitosis for anti-cancer therapy: is cell death the only answer?

Authors:  Manuel Haschka; Gerlinde Karbon; Luca L Fava; Andreas Villunger
Journal:  EMBO Rep       Date:  2018-02-19       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.